APA

Foster B. J., Newell D. R., Graham M. A., Gumbrell L. A., Jenns K. E., Kaye S. B. & Calvert A. H. (19920626). Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalation. : European journal of cancer (Oxford, England : 1990).

Chicago

Foster B J, Newell D R, Graham M A, Gumbrell L A, Jenns K E, Kaye S B and Calvert A H. 19920626. Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalation. : European journal of cancer (Oxford, England : 1990).

Harvard

Foster B. J., Newell D. R., Graham M. A., Gumbrell L. A., Jenns K. E., Kaye S. B. and Calvert A. H. (19920626). Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalation. : European journal of cancer (Oxford, England : 1990).

MLA

Foster B J, Newell D R, Graham M A, Gumbrell L A, Jenns K E, Kaye S B and Calvert A H. Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalation. : European journal of cancer (Oxford, England : 1990). 19920626.